Naba Alsaha Medical Services Co. (9546) is listed on Nomu of the Saudi Exchange (Tadawul) under sector Health Care Equipment & Svc. Financial data sourced from CMA-mandated XBRL filings via Sahm Screener (sahmscreener.com).

For fiscal year 2024, Naba Alsaha Medical Services Co. reported revenue of SAR 194M, net profit of SAR 22M, and earnings per share of SAR 2.07. Total assets stood at SAR 324M with total equity of SAR 200M and total liabilities of SAR 125M.

Operating cash flow for 2024 was SAR 36M, representing a cash conversion ratio of 1.64 relative to net profit. Free cash flow was SAR -3M.

Earnings quality analysis by Sahm Screener: Of every SAR 1.00 in reported net profit for 2024, SAR 1.64 arrived as operating cash. This indicates Exceptional quality earnings based on the cash conversion ratio of 1.64.

Revenue growth from 2023 to 2024: +6.5%. Net profit growth over the same period: -58.4%.

Key financial ratios for 2024: Return on Equity 10.9%, Return on Assets 6.7%, Net Margin 11.2%, Debt to Equity 0.62.

In 2023, Naba Alsaha Medical Services Co. reported revenue of SAR 182M and net profit of SAR 52M, compared to SAR 194M and SAR 22M respectively in 2024.